INNOVATIVE GRANT HELPS RESEARCHERS EXPLORE NEW HORIZONS

APDA recently hosted the Diversity in Parkinson’s Disease Research Roundtable virtual program...see more to highlight the exciting work we’ve been funding in this area. We know that PD affects people of all ethnicities, ancestries, and geographies, yet for many years, research efforts failed to reflect that. Unfortunately, many clinical […]

Read More

A new device dramatically improves freezing of gait in an individual with PD

Freezing of gait (FOG) is an abnormal gait pattern that can accompany Parkinson’s disease (PD) as well as other parkinsonian...see more disorders in which there are sudden, short, and temporary episodes of an inability to move the feet forward despite the intention to walk. These episodes can significantly  interfere in daily life and can result in falls. Treatments […]

Read More

Spinal Cord Stimulation as Potential Treatment for Gait Issues

Gait impairment can be a significant challenge as Parkinson’s disease (PD) advances, with balance problems, frequent falls, and freezing...see more of gait impeding quality of life. Often these challenges do not respond to increased amounts of PD medication or deep brain stimulation (DBS). In recent years, electrical stimulation of the spinal cord has been a research […]

Read More

HOPE IN PROGRESS: NEW RESEARCH UNDERWAY

From understanding levodopa induced dyskinesias to exploring environmental risk factors of PD, APDA-funded...see more researchers launch cutting-edge studies With someone diagnosed with PD every six minutes, scientific research is critical as we push for better treatments and ultimately, a cure. Devoted to our search for answers, APDA recently awarded $1.975 […]

Read More

SAGE THERAPEUTICS CLINICAL RESEARCH

Clinical Research Study in Mild Cognitive Impairment associated with Parkinson’s Disease (PD-MCI) The PRECEDENT study...see more is evaluating an investigational treatment for cognitive deficits such as memory and attention in Parkinson’s. This phase 2 study is sponsored by Sage Therapeutics, Inc. and is recruiting people aged 50 to 75 years who are […]

Read More